5550024 Genetic markers for pig litter size

5550024 Genetic markers for pig litter size

422 PATENT ABSTRACTS fragment from pLM63, preferably with a nucleic acid. Such nucleic acids are suitable for hybridization tests for Listeria bacte...

63KB Sizes 5 Downloads 118 Views

422

PATENT ABSTRACTS

fragment from pLM63, preferably with a nucleic acid. Such nucleic acids are suitable for hybridization tests for Listeria bacteria if they contain reporter groups. Proteins are also described which are suitable for the production of antibodies against Listeria bacteria.

5550029 M E T H O D FOR DIAGNOSING E S T R O G E N RESPONSIVENESS Simpkins James W; Bishop Jean Gainesville, FL, UNITED STATES Assigned to University of Florida

5550024 GENETIC M A R K E R S F O R PIG LITTER SIZE Rothschild Max; Tuggle Christopher K; Jacobson Carol; Vaske David A; Mileham Alan J; Plastow Graham Ames, IA, UNITED STATES Assigned to Bioteehnology Research & Development Corporation; Iowa State University Research Foundation Inc Disclosed herein are genetic markers for pig litter size, methods for identifying such markers, and methods of screening pigs to determine those more likely to produce larger fitters and preferably selecting those pigs for future breeding purposes based on the ESR polymorphisms. The markers are based upon the presence or absence of certain polymorphisms in the pig estrogen receptor gene. Preferably, the polymorphism is a restriction fragment length polymorphism (RFLP).

5550028 T E T R A H Y D R O X Y Q U I N O N E AS AN A C T I V A T O R C O M P O N E N T FOR A C T I V A T E D PARTIAL T H R O M B O P L A S T I N TIME TEST OF B L O O D COAGULATION Lee Ted C; Pelzer Franz; Motley Leslie A Plantation, FL, UNITED STATES Assigned to Dade International lnc The compound 2,3,5,6-tetrahydroxy- 1,4-quinone, its derivatives and structural analogs are used as activators for intrinsic blood coagulationand as diagnostic reagents for the activated partial thromboplastin time test of blood coagulation.

A method and diagnostic kit is provided for diagnosing responsiveness to a hormone in a human subject that includes determining the amount of glucose utilized by a sample taken from the subject in the presence of the hormone. The sample taken from the subject may include body fluid or body tissue such as blood or skin. The glucose ufflized in the test may be labelled for example, with a radioactive label. The diagnostic test may be used to determine responsiveness to estrogen in a human subject prior to treatment with hormone replacement therapy.

5550030 REAGENT FOR ENDOTOXIN-SPECIFIC ASSAY Tanaka Shigenori; Tamura Hiroshi; Ohki Makoto Tokyo, JAPAN Assigned to Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Disclosed are a reagent for endotoxin-spocific assay which comprises an insoluble carrier having immobilized thereon at least an endotoxin-sansitive factor derived from a limulus amebocyte; a kit for endotoxin-specific assay containing said reagent and a substrate for activated factor C or a substrate for clotting enzyme; a method for assaying endotoxin comprising applying a sample solution to said reagent to cause endotoxin in the sample to react with factor C in said reagent and determining a change of a subswate; and a process for preparing said reagent which comprises physically or chemically immobilizing at least an endotoxin-sensitive factor derived from a fimuhis amebocyte on an insoluble carrier. Endotoxin in a sample, even turbid or colored, can be specifically assayed with ease and rapidness without the influence of a (1 right arrow3)beta-glucan.